“Conclusions: The significant difference in absorption of domperidone on pretreatment with silymarin is due to the inhibition of P-glycoprotein and CYP3A.”
“ Silymarin , which inhibits CYP3A4, should be contraindicated for domperidone.”
“The silymarin pretreatment increased the bioavailability of domperidone.”